Gastrointestinal Oncology
The organisation demonstrates substantial engagement in advancing treatment strategies for digestive system malignancies. Research initiatives encompass comprehensive investigations into colorectal cancer, including both metastatic colorectal carcinoma and localised disease presentations. The sponsor supports studies examining peritoneal metastases and their surgical management through cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. Additional focus areas include gastric cancer and gastroesophageal junction tumours, with particular attention to locally advanced disease stages.
- Colorectal Cancer Treatment Optimization
- Peritoneal Surface Malignancies
- Upper Gastrointestinal Tumours
- Multimodal Therapy Approaches
Research programmes explore the integration of perioperative chemotherapy regimens and assess the role of neoadjuvant therapy in improving surgical outcomes and patient survival rates.
Hepatobiliary and Pancreatic Malignancies
The sponsor maintains active research programmes addressing cancers of the hepatobiliary system and pancreas. Investigations focus on pancreatic adenocarcinoma, including both resectable and borderline resectable disease presentations. Studies examine hepatocellular carcinoma and various forms of cholangiocarcinoma, including intrahepatic, perihilar, and extrahepatic bile duct cancers. The research portfolio includes evaluations of ampullary carcinoma and other rare biliary tract malignancies.
- Pancreatic Cancer Therapeutics
- Biliary Tract Carcinomas
- Primary Liver Cancers
- Perioperative Treatment Strategies
Clinical investigations emphasise the development of adjuvant therapy protocols and the optimisation of surgical timing in relation to systemic treatment administration.
Surgical Oncology Integration
Research activities demonstrate significant emphasis on combining surgical interventions with systemic therapies. The organisation supports trials evaluating complete cytoreduction procedures and their integration with chemotherapy regimens. Studies investigate optimal sequencing of surgical resection with perioperative medical treatments, particularly in cases of oligometastatic disease and locally advanced tumours. Research encompasses assessment of resectability criteria and surgical decision-making following systemic therapy response.
- Cytoreductive Surgical Techniques
- Perioperative Therapy Timing
- Oligometastatic Disease Management
- Surgical Outcome Optimization
Investigations examine the impact of intraperitoneal chemotherapy delivery methods and evaluate survival benefits associated with aggressive surgical approaches in advanced disease presentations.
Advanced and Metastatic Disease Management
The sponsor’s research portfolio addresses treatment challenges in advanced stage cancers and metastatic disease. Studies focus on patients with synchronous metastases and explore therapeutic strategies for peritoneal carcinomatosis. Research programmes investigate management of oligometastatic colorectal cancer and evaluate treatment approaches for patients with unresectable disease that may become amenable to surgical intervention following systemic therapy.
- Metastatic Disease Treatment
- Peritoneal Carcinomatosis Therapy
- Conversion Therapy Strategies
- Advanced Stage Disease Protocols
Clinical trials assess the effectiveness of intensive combination chemotherapy regimens and their role in converting initially unresectable tumours to surgically manageable disease.
